MD1788G2 - Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase - Google Patents

Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase

Info

Publication number
MD1788G2
MD1788G2 MD97-0243A MD970243A MD1788G2 MD 1788 G2 MD1788 G2 MD 1788G2 MD 970243 A MD970243 A MD 970243A MD 1788 G2 MD1788 G2 MD 1788G2
Authority
MD
Moldova
Prior art keywords
erythromycin
treatment
pharmaceutical composition
infectious diseases
base
Prior art date
Application number
MD97-0243A
Other languages
English (en)
Russian (ru)
Other versions
MD970243A (ro
MD1788F2 (ro
Inventor
Franco PELLACINI (IT)
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Group S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S.P.A. filed Critical Zambon Group S.P.A.
Publication of MD970243A publication Critical patent/MD970243A/ro
Publication of MD1788F2 publication Critical patent/MD1788F2/ro
Publication of MD1788G2 publication Critical patent/MD1788G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MD97-0243A 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase MD1788G2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (3)

Publication Number Publication Date
MD970243A MD970243A (ro) 1999-05-31
MD1788F2 MD1788F2 (ro) 2001-11-30
MD1788G2 true MD1788G2 (ro) 2002-05-31

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0243A MD1788G2 (ro) 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase

Country Status (35)

Country Link
US (1) US5847092A (ro)
EP (1) EP0797579B1 (ro)
JP (1) JPH10510520A (ro)
KR (1) KR100367559B1 (ro)
CN (1) CN1046535C (ro)
AP (1) AP739A (ro)
AT (1) ATE190620T1 (ro)
AU (1) AU690791B2 (ro)
BG (1) BG63261B1 (ro)
BR (1) BR9510015A (ro)
CA (1) CA2207029A1 (ro)
CZ (1) CZ289943B6 (ro)
DE (1) DE69515694T2 (ro)
DK (1) DK0797579T3 (ro)
EE (1) EE03401B1 (ro)
ES (1) ES2144154T3 (ro)
FI (1) FI972493A (ro)
GE (1) GEP20012391B (ro)
GR (1) GR3033622T3 (ro)
HU (1) HU220631B1 (ro)
IT (1) IT1276901B1 (ro)
LT (1) LT4276B (ro)
LV (1) LV11898B (ro)
MD (1) MD1788G2 (ro)
NO (1) NO309816B1 (ro)
NZ (1) NZ297446A (ro)
OA (1) OA10491A (ro)
PL (1) PL182053B1 (ro)
PT (1) PT797579E (ro)
RO (1) RO116282B1 (ro)
RU (1) RU2152951C1 (ro)
SI (1) SI9520124A (ro)
TJ (1) TJ306B (ro)
UA (1) UA48958C2 (ro)
WO (1) WO1996018633A1 (ro)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033255A1 (fr) * 1980-01-11 1981-08-05 Roussel-Uclaf Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0487411B1 (fr) * 1990-11-21 1996-01-31 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
PT86800B (pt) 1987-02-24 1992-05-29 Beecham Group Plc Processo para a preparacao de derivados de eritromicina
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033255A1 (fr) * 1980-01-11 1981-08-05 Roussel-Uclaf Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0487411B1 (fr) * 1990-11-21 1996-01-31 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments

Also Published As

Publication number Publication date
GR3033622T3 (en) 2000-10-31
ITMI942496A1 (it) 1996-06-13
CN1169727A (zh) 1998-01-07
AU690791B2 (en) 1998-04-30
MD970243A (ro) 1999-05-31
MD1788F2 (ro) 2001-11-30
ITMI942496A0 (it) 1994-12-13
KR100367559B1 (ko) 2003-04-21
EP0797579B1 (en) 2000-03-15
PL320688A1 (en) 1997-10-27
JPH10510520A (ja) 1998-10-13
DE69515694D1 (de) 2000-04-20
HUT77126A (hu) 1998-03-02
FI972493A0 (fi) 1997-06-12
RU2152951C1 (ru) 2000-07-20
DK0797579T3 (da) 2000-06-05
PT797579E (pt) 2000-08-31
HU220631B1 (hu) 2002-03-28
RO116282B1 (ro) 2000-12-29
CA2207029A1 (en) 1996-06-20
UA48958C2 (uk) 2002-09-16
NZ297446A (en) 1999-06-29
LV11898B (en) 1998-03-20
ES2144154T3 (es) 2000-06-01
CN1046535C (zh) 1999-11-17
AP739A (en) 1999-03-24
AU4260396A (en) 1996-07-03
EE9700124A (et) 1997-12-15
ATE190620T1 (de) 2000-04-15
OA10491A (en) 2002-04-10
FI972493A (fi) 1997-06-12
WO1996018633A1 (en) 1996-06-20
AP9700989A0 (en) 1997-07-31
CZ178697A3 (en) 1997-12-17
BG101570A (en) 1998-02-27
NO309816B1 (no) 2001-04-02
BG63261B1 (bg) 2001-07-31
IT1276901B1 (it) 1997-11-03
BR9510015A (pt) 1997-10-28
DE69515694T2 (de) 2000-10-26
US5847092A (en) 1998-12-08
SI9520124A (sl) 1998-04-30
NO972702D0 (no) 1997-06-12
NO972702L (no) 1997-08-13
EP0797579A1 (en) 1997-10-01
MX9704253A (es) 1997-09-30
PL182053B1 (pl) 2001-10-31
TJ306B (en) 2001-08-06
CZ289943B6 (cs) 2002-04-17
GEP20012391B (en) 2001-03-25
LV11898A (lv) 1997-12-20
EE03401B1 (et) 2001-04-16
LT4276B (lt) 1998-01-26
LT97116A (en) 1997-10-27

Similar Documents

Publication Publication Date Title
MD1233B1 (ro) Derivati de eritromicina, procedeu de preparare a lor si compozitie farmaceu-tica pe baza acestora
CA2145826A1 (en) Lipopeptide derivatives, a process for their preparation and their use
AU6114699A (en) Naphthrydine compounds and their azaisosteric analogues as antibacterials
MX9700885A (es) Nuevas heteroariloxazolidinonas.
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
NZ514917A (en) Ketolide antibacterials
AU544790B2 (en) Epimeric azahomoerythromycin a derivatives
AU1747201A (en) Compounds with antibacterial and antiparasitic properties
WO2000026224A3 (en) Novel macrolide antibiotics
IL123551A0 (en) Tricyclic erythromycin derivatives
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
MX9708696A (es) Cefalosporinas antibacterianas.
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
MX9708611A (es) Compuestos de dialquiltiacumicina.
AU2998797A (en) 6-o-substituted erythromycin compounds and method for making same
CA2176144A1 (en) Anthracycline derivatives for treatment of amyloidosis
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
AU644474B2 (en) Heteroarylmethylbenzenes
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
GR3031709T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use.
IL123386A0 (en) 3-Deoxy-3-descladinose derivatives of erythromycins
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
ATE222262T1 (de) Antibiotisch wirksame stalobacine

Legal Events

Date Code Title Description
PD99 Pending application
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees